Chief Technical Ops Officer of PTC THERAPEUTICS, INC. (U.S.: Nasdaq:PTCT), Almstead Neil Gregory, sells 756 shares worth $29,125
According to PTC THERAPEUTICS, INC.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 11 04:20 PM, company Chief Technical Ops Officer, Almstead Neil Gregory disclosed selling 756 shares at a cost of $38.52. At the time of this transaction (Jan 07), this trade was worth $29,125 in total. As of Jan 07, Almstead Neil Gregory now owns 35,058 shares in total worth about $1,421,251.32.
For the last few recent trades made by PTC THERAPEUTICS, INC. (U.S.: Nasdaq:PTCT) Chief Technical Ops Officer, Almstead Neil Gregory, we have the following information:
- SEC Form 4 filing: Jan 07: Sold 45 shares at the rate of $38.52 per share. Total worth of this trade was $1,734. Total number of shares owned as of Jan 07 were 1,710
- SEC Form 4 filing: Jan 04: Sold 64 shares at the rate of $41.16 per share. Total worth of this trade was $2,634. Total number of shares owned as of Jan 04 were 1,755
- SEC Form 4 filing: Feb 01: Sold 973 shares at the rate of $56.96 per share. Total worth of this trade was $55,418. Total number of shares owned as of Feb 01 were 35,814
Posted by
George Daniels
on Tuesday January 11 2022, 11:04 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
